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ABSTRACT Apurinic/apyrimidinic endonuclease 1 (APE1) is a multifunctional protein contrib-
uting to genome stability via repair of DNA lesions via the base excision repair pathway. It 
also plays a role in gene expression regulation and RNA metabolism. Another, poorly charac-
terized function is its ability to bind to negative calcium responsive elements (nCaRE) of some 
gene promoters. The presence of many functional nCaRE sequences regulating gene tran-
scription can be envisioned, given their conservation within ALU repeats. To look for func-
tional nCaRE sequences within the human genome, we performed bioinformatic analyses and 
identified 57 genes potentially regulated by APE1. We focused on sirtuin-1 (SIRT1) deacety-
lase due to its involvement in cell stress, including senescence, apoptosis, and tumorigenesis, 
and its role in the deacetylation of APE1 after genotoxic stress. The human SIRT1 promoter 
presents two nCaRE elements stably bound by APE1 through its N-terminus. We demon-
strate that APE1 is part of a multiprotein complex including hOGG1, Ku70, and RNA Pol II, 
which is recruited on SIRT1 promoter to regulate SIRT1 gene functions during early response 
to oxidative stress. These findings provide new insights into the role of nCaRE sequences in 
the transcriptional regulation of mammalian genes.
INTRODUCTION
Apurinic/apyrimidinic endonuclease 1 (APE1), also known as redox 
effector factor-1 (Ref-1), is a multifunctional and essential protein in 
mammals. It plays a vital role during cellular response to oxidative 
stress (Fung and Demple, 2005) and contributes to the maintenance 
of genome integrity (Tell et al., 2005, 2009, 2010a). As an AP endo-
nuclease, APE1 is involved in the base excision repair (BER) pathway, 
which deals with DNA damage induced by oxidative and alkylating 
agents, including chemotherapeutic agents (Chen and Stubbe, 
2005). APE1 also has transcriptional regulatory activity, modulating 
gene expression through a redox-based coactivating function on 
several transcription factors involved in cancer promotion and pro-
gression (Huang and Adamson, 1993; Tell et al., 1998; Gaiddon 
et al., 1999). These two major APE1 activities are independent and 
located in distinct protein domains. The N-terminal portion of the 
protein is devoted to the transcriptional coactivating function, and 
the C-terminal domain exerts the endonuclease activity on DNA 
abasic sites (Xanthoudakis et al., 1996; Tell et al., 2005). The latter 
domain is highly conserved, whereas the N-terminal region presents 
wider variability among different organisms, being more conserved 
in mammals, thus suggesting recent acquisition during evolution 
(Georgiadis et al., 2008; Fantini et al., 2010; Poletto et al., 2013). 
Through its N-terminal portion, APE1 also interacts with different 
proteins involved in ribosome biogenesis, pre-mRNA maturation/
splicing, and ribonucleotide catabolism. These observations high-
light an unexpected role of APE1 in RNA metabolism (Vascotto 
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To this purpose, classic DNA pattern-matching studies are inte-
grated with independent information on gene regulation. We use 
three main sources for data filtering: 1) functional annotation data 
collected via the Gene Ontology (GO) project; 2) gene expression 
data derived from the microarray profile of APE1-knockdown HeLa 
cells (Vascotto et al., 2009a); and 3) human–mouse gene sequence 
comparisons. In fact, both expression data and functional annota-
tion database provide a wealth of information about coregulation. 
This is of particular interest, since coregulated genes likely share 
similar transcriptional regulatory mechanisms. Comparison with or-
thologous gene promoters highlights sequences retained during 
evolution, whose conservation suggests their potential functionality. 
As a final result, we obtain a set of genes that pass the mentioned 
filters and are considered bona fide candidates coregulated through 
nCaRE-B sequences (Supplemental Figure S1).
We collected the 6000–base pair upstream regions of all human 
and mouse protein-coding genes, which we then analyzed for the 
presence of nCaRE-B elements using Glsearch for local alignment 
(Pearson, 2000). We found 8724 human genes to contain one or 
more nCaRE-B matches within their promoters; 2173 matches were 
retrieved in the mouse genome. We then cross-checked candidate 
genes with gene expression data obtained from APE1-knockdown 
cells (Vascotto et al., 2009a), verifying coexpression between genes 
carrying nCaRE-B elements. Through this analysis, we identified 384 
common genes in the two data sets (Figure 1A). Then we considered 
the GO annotations of these 384 genes, searching for statistically 
significant common annotations. We observed strong overrepresen-
tation of terms related to RNA processing and metabolism, in ac-
cordance with our previous studies (Vascotto et al., 2009a). All the 
significant associations between genes and GO terms are reported 
in Supplemental Table S1. Finally, we applied the phylogenetic foot-
printing filter, which evaluates whether a significant fraction of the 
selected genes, as obtained through the GO filter, share homolo-
gous genes containing nCaRE-B-related sequences in the upstream 
region with respect to the mouse gene data set. As a final result, we 
extracted 57 genes that may be considered bona fide candidates 
bearing the putative nCaRE-B sequences within their regulatory ele-
ments (Supplemental Table S2). We performed a functional enrich-
ment analysis to determine whether the 57 genes found are involved 
in common biological processes. This showed that candidate genes 
were associated with processes related to gene expression, activa-
tion, or increment of the extent of transcription from an RNA poly-
merase II–driven promoter (Figure 1B and Supplemental Table S3). 
Among these 57 genes, several are involved with DNA repair pro-
cess and cellular response to external stimuli and DNA damage: for 
example, SWI/SNF-related, matrix-associated, actin-dependent reg-
ulator of chromatin, subfamily a member 4 (SMARCA4), sirtuin 1 
(SIRT1), valosin-containing protein (VCP), multiple endocrine neo-
plasia I (MEN1), structural maintenance of chromosomes protein 6 
(SMC6), early growth response 1 (EGR-1), and APE1 itself. We paid 
particular attention to SIRT1, a NAD-dependent histone deacetylase 
belonging to class III of the sirtuin family, based on the recent dem-
onstration of a functional involvement of this enzyme in the deacety-
lation of some K residues in the N-terminal region of APE1 (Yamamori 
et al., 2010; Lirussi et al., 2012). The latter information and the data 
derived from our bioinformatic analysis led us to hypothesize the 
existence of an autoregulatory loop between APE1 and SIRT1.
APE1 binds the nCaRE-B sequences present in the human 
SIRT1 promoter
To prove the functional relevance of the nCaRE-B sequences identi-
fied in the human SIRT1 promoter, we first tested the ability of APE1 
et al., 2009b; Tell et al., 2010b), as also shown by two independent 
studies that demonstrated the ability of APE1 to cleave abasic RNA 
in vitro and in vivo (Berquist et al., 2008; Barnes et al., 2009). Ac-
cordingly, APE1 has been proposed to be a main factor in the abasic 
RNA cleansing process, suggesting that some of the activities of 
APE1 in gene expression may involve posttranscriptional mecha-
nisms (Tell et al., 2010b).
Another interesting, yet poorly characterized aspect of APE1 
transcriptional activity is its role as a component of a trans-acting 
complex that acts as a Ca2+-dependent repressor of the parathyroid 
hormone (PTH) gene by binding the negative calcium responsive 
elements (nCaRE) in its promoter region (Okazaki et al., 1991). In 
particular, an increase in extracellular Ca2+ concentration inhibits 
PTH expression through a mechanism involving APE1 binding to 
two nCaRE elements, nCaRE-A and nCaRE-B (Yamamoto et al., 
1989). This observation was further extended to the promoter re-
gion of renin (Fuchs et al., 2003), Bax (Bhattacharyya et al., 2009), 
and APE1 itself (Izumi et al., 1996). This last case represents the first 
example of such a negative regulatory mechanism for a DNA repair 
enzyme. Other experiments demonstrated that APE1 requires ad-
ditional factors, such as heterogeneous ribonucleoprotein L 
(Kuninger et al., 2002), Ku antigen (Chung et al., 1996), and PARP-1 
(Bhattacharyya et al., 2009), to stably bind to nCaRE elements.
nCaRE-B sequences are located within ALU repeats (McHaffie 
and Ralston, 1995; Shankar et al., 2004). Therefore, given that ALU 
elements are transposable elements that occupy at least 1/10 of the 
expressed human genome, many other functional nCaRE-B se-
quences could exist and play a role in the transcriptional regulation 
of genes. However, information is lacking on 1) an accurate number-
ing, 2) the identity of genes containing these sequences within their 
promoter, and 3) the active biological function of these elements. 
Thus the quest is for functional nCaRE-B sequences in the human 
genome to identify new potential genes whose expression may be 
regulated by APE1 through nCaRE binding.
The present work is devoted to this issue and focuses on the 
characterization of the molecular mechanisms responsible for APE1 
binding to nCaRE-B sequences on sirtuin-1 (SIRT1) promoter. Bioin-
formatic analyses of human gene expression data obtained upon 
APE1 knockdown in cells (Vascotto et al., 2009a) show the presence 
of multiple nCaRE-B sequences in genes deregulated upon APE1 
silencing and conserved in the mouse genome. Among these, we 
focus on the two nCaRE sequences present within the promoter re-
gion of the human deacetylase SIRT1 gene and their role in regulat-
ing the corresponding gene transcription. SIRT1 is a deacetylase 
participating in cell growth, adaptation to caloric restriction, apop-
tosis, and tumorigenesis (Gorospe and de Cabo, 2008; Kim and Um, 
2008), as well as in cell response to genotoxic agents through the 
deacetylation of APE1 (Yamamori et al., 2010). Together the data 
show the importance of APE1 during transcriptional initiation in 
positively promoting transcription of genes under genotoxic 
conditions.
RESULTS
Bioinformatic search for nCaRE sequence–containing genes 
reveals the SIRT1 gene as a novel candidate target of APE1 
regulation
Bioinformatic analysis of the systematic retrieval of functional nCaRE-
B sequences in the human genome was carried out by filtering bio-
logical data obtained from the gene expression profile of HeLa cells 
knocked down for APE1 (Vascotto et al., 2009a). Here we develop a 
method that integrates different approaches to the problem on a 
whole-genome scale while minimizing the number of false positives. 
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importance of the first 33 amino acids at the APE1 N-terminus for 
proper binding of the protein to nCaRE-B sequences. Similar poor 
DNA-binding activity was apparent in the case of zAPE1 (Figure 2B, 
lanes 4 and 8), which bears a nonrelated N-terminal domain (Fantini 
et al., 2010). Together these results suggest that the phylogeneti-
cally evolved N-terminal domain of the protein is essential for stable 
interaction between APE1 and the nCaRE-B sequences. It is con-
ceivable that K residues present within this region and acquired dur-
ing evolution in mammals (Georgiadis et al., 2008; Fantini et al., 
2010; Poletto et al., 2013) play a major role in protein binding to 
these DNA elements.
We then estimated the affinity of APE1 for SIRT1 nCaRE-B se-
quences through surface plasmon resonance (SPR) analysis 
(Figure 2C). Biotinylated versions of the nCaRE-B (SIRT1-B) or polyT 
to specifically bind these elements in vitro. Thus we performed elec-
trophoretic mobility shift assay (EMSA) analyses using different APE1 
recombinant protein forms and two double-stranded (ds) oligonu-
cleotides containing the SIRT1 nCaRE-B elements corresponding to 
the sequences present at −2701 (SIRT1-A) and −1754 base pairs 
(SIRT1-B) from the transcription start site (TSS), respectively 
(Figure 2A). Full-length human wild-type (WT) APE1 (APE1WT), the 
N-terminal APE1-deletion mutant (APE1NΔ33), and the orthologous 
zebrafish APE1 (zAPE1) expressed in Escherichia coli were used for 
this purpose. As clearly demonstrated by EMSA analyses, only the 
APE1WT protein was able to stably bind to both the SIRT1 nCaRE-B 
sequences (Figure 2B, lanes 2 and 6), whereas a complete absence 
of retarded complex was observed in the case of the truncated 
APE1NΔ33 form (Figure 2B, lanes 3 and 7). These findings show the 
FIGURE 1: Bioinformatic research on nCaRE sequences. (A) Results obtained from the application of the different filters. 
Top, data derived from alignment research on nCaRE sequences on human gene promoters and subsequent cross-
checking with microarray data. Bottom, final results from combined GO and phylogenetic footprinting analyses. 
(B) Functional enrichment analysis of the 57 putative genes regulated by APE1 performed according to their biological 
process annotations. For simplicity, only the most representative functional categories are reported. The number of 
genes for each category is provided on the horizontal axis, together with the list of the first 17 co-occurrence terms. 
Statistical significance for each category is shown within each bar.
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FIGURE 2: APE1 is part of a nuclear protein complex that binds to the SIRT1 nCaRE sequence through its N-terminal 
domain. (A) Schematic representation (top) and multiple sequence alignment (bottom) of two nCaRE-B sequences found 
on the human SIRT1 gene promoter (SIRT1-A and SIRT1-B) with the nCaRE sequence found on the human PTH 
promoter (Okazaki et al., 1991). (B) EMSA analysis of nCaRE SIRT1-A and SIRT1-B sequence challenged with 10 pmol of 
purified APE1WT, APE1NΔ33, and zAPE1 proteins. Left, Coomassie staining of the purified recombinant proteins. (C) SPR 
analysis of the human APE1 (hAPE1)–nCaRE interaction. Recombinant hAPE1 and biotinylated nCaRE SIRT1-B (Table 1) 
were used as analyte and ligand, respectively. Plot of RUmax from each binding vs. hAPE1 concentrations (0.5–8 μM); 
data were fitted by nonlinear regression analysis. (D) Top, EMSA analysis of nCaRE SIRT1-B incubated with HeLa nuclear 
extract of different clones: control clone, APE1SCR-1 (lane 2), clone silenced for APE1, APE1CL.3 (lane 3), and clones 
reconstituted with APE1WT (lane 4) or APE1NΔ33 (lane 5). Bottom, Western blot analysis of APE1 protein in HeLa nuclear 
cell extracts. (E) EMSA analysis of nCaRE SIRT1-B with HeLa nuclear extract from APE1SCR-1 clone alone (lane 2) or 
preincubated with monoclonal antibody against APE1 (lane 3) or/and with an antibody against Ku-70 (lanes 4 and 5). 
Lane 6 corresponds to APE1SCR-1 nuclear extract incubated with a nonspecific antibody (α-P2Y6). Free indicates probe 
alone; F shows the position of the free oligonucleotide probe. Specific APE1/nCaRE interaction is indicated by the 
arrow. Asterisk indicates supershift.
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nCaRE-B elements of the SIRT1 promoter. The reduced intensity of 
the retarded complex band upon APE1 silencing or in the reconsti-
tuted cells expressing APE1NΔ33 protein (Figure 2D), as well as 
the lower apparent electrophoretic mobility of the protein–DNA 
retarded complex when using nuclear extracts in place of the 
recombinant purified protein (Figure 2B), suggests that APE1 may 
be part of a multiprotein complex. Because Ku70 antigen protein 
was already demonstrated to bind nCaRE-A sequences in complex 
with APE1 (Chung et al., 1996), we incubated the HeLa nuclear ex-
tract with an antibody recognizing the Ku70 antigen. We then sub-
jected the reaction to EMSA analysis, showing the formation of a 
supershifted complex (Figure 2E, lane 4). The concurrent presence 
of APE1 and Ku70 in the same retarded complex was confirmed by 
performing simultaneous preincubation with antibodies specific for 
these proteins (Figure 2E, lane 5). The presence of Ku70 in the com-
plex with APE1 was also corroborated by additional EMSA analysis 
performed with the purified recombinant protein attesting that, 
when present alone, Ku70 is not able to stably bind to the SIRT1 
nCaRE-B sequence per se. On the contrary, when concomitantly in-
cubated with APE1, Ku70 significantly enhances APE1 DNA-binding 
activity to SIRT1 nCaRE-B element (Supplemental Figure S3, com-
pare lanes 2–5 and 8–10). Unpublished data demonstrated that this 
stimulatory activity on APE1 binding required interaction through 
the APE1 33N-terminal domain. Overall these data demonstrate 
that APE1 must be part of a multiprotein complex containing Ku70 
to elicit its high-affinity binding potential with regard to the nCaRE-B 
sequences present on the SIRT1 promoter.
Topology of the APE1-nCaRE complex
nCaRE-B element consists of a palindromic sequence that can fold 
into self-complementary hairpins (Figure 3A, left). In silico analyses 
with the mfold program suggested that these elements could fold 
into cruciform-like structures. To evaluate whether SIRT1 nCaRE-B 
sequences can fold into cruciform duplexes and specifically assess 
whether APE1 binding to this element may depend on such second-
ary structures, we performed footprinting analyses by using the T7 
endonuclease I (Figure 3A, right). This protein is a structure-sensitive 
enzyme that specifically recognizes conformationally branched DNA 
and Holliday structures or junctions (Parkinson and Lilley, 1997; Dé-
clais et al., 2003; Fan et al., 2006). Footprinting data support the 
hypothesis of the existence of a secondary structure for the nCaRE-
B sequences (Figure 3A and Supplemental Figure S4). In particular, 
our experiments show the predominant formation of two bands (re-
spectively 10 and 19 nucleotides in length) in the digested samples, 
which correspond to a cutting site close to the predicted loop or 
immediately adjacent to the predicted stem (Figure 3A, arrows). Of 
interest, preincubation of the SIRT1 nCaRE-B oligonucleotide with 
APE1 impairs T7 endonuclease digestion (Figure 3A, lane 4). Con-
sistent with these observations, EMSA analysis demonstrated that 
digestion of the SIRT1 nCaRE-B oligonucleotide with T7 endonu-
clease affects APE1 binding to this element, but, conversely, when 
APE1 was first incubated with the nCaRE-B probe and then digested 
with T7 endonuclease, the binding was not affected. These data 
suggest a protective role of APE1 with regard to T7 endonuclease 
action, strongly supporting the hypothesis that these proteins may 
compete for the same binding site on the nCaRE-B sequences 
(Figure 3B).
The first 33 N-terminal amino acids of APE1 are required for pro-
tein binding to the nCaRE sequences (Figure 2, A and D). To further 
investigate the role of this protein portion on APE1’s ability to bind 
to DNA elements, we performed combined limited proteolysis-mass 
spectrometry experiments on recombinant APE1 protein in either 
sequences were immobilized onto a streptavidin chip for use as li-
gands in SPR experiments. APE1WT and APE1NΔ33 were then ana-
lyzed for their DNA-binding properties. When testing APE1WT as 
analyte, KD = 3.90 ± 0.08 μM was measured (Poletto et al., 2013); 
corresponding kinetic parameters are shown in Table 1. Conversely, 
when using APE1NΔ33, we did not observe any SPR signal variation 
(unpublished data), in accordance with EMSA experiments 
(Figure 2B). This result confirmed that the protein region 1–33 is es-
sential for stable interaction of APE1 with these DNA elements. As a 
DNA-repair enzyme, APE1 has intrinsic ability to bind to DNA in a 
sequence-independent manner. Moreover, independent observa-
tions clearly point to a role of the nucleic acid secondary structure in 
positively modulating this activity (Poletto et al., 2013). Here we 
evaluated the protein capacity to bind to a single-stranded 24-mer 
oligo-dT (here called polyT). A KD = 308 ± 3 μM was measured in the 
case of APE1WT, whereas no binding was observed for APE1NΔ33 
(Table 1 and Supplemental Figure S2), in agreement with EMSA 
analysis. These results indicate that APE1 poorly recognizes a non-
structured oligonucleotide formed by a stretch of thymidines, con-
firming that this protein may bind to DNA with different affinities 
and the oligo-dT sequence may be used in EMSA analysis as a non-
specific competitor.
Our EMSA and SPR analyses on APE1 binding activity to the 
SIRT1 nCaRE-B sequences showed low affinity for recombinant 
APE1 alone. Therefore we tested whether additional factors present 
in nuclear extracts of the cells may increase protein-binding affinity 
to its oligonucleotide target. To this aim, further EMSA analyses, 
performed using HeLa cell nuclear fractions, confirmed that nuclear 
activity able to specifically bind nCaRE-B sequences was indeed 
present (Figure 2D). The high-affinity complex measured, even us-
ing much lower amounts of APE1 (0.63 pmol, as estimated from Li-
russi et al., 2012) with respect to that obtained with the recombinant 
purified protein alone (10 pmol; Figure 2B), suggested that addi-
tional factors are required for efficient APE1 binding to SIRT1 
nCaRE-B sequences. To demonstrate the presence of APE1 in the 
retarded complex observed in Figure 2D, we used nuclear extracts 
obtained from a HeLa line (CL.3) for which endogenous APE1 pro-
tein expression was previously knocked down through stable short 
hairpin RNA (shRNA) transfection (Vascotto et al., 2009a). As is ap-
parent from lane 3 in Figure 2D, an overall reduction of the intensity 
(almost 70% with respect to lane 2) of the retarded nCaRE-bound 
complex was observed, similar to what occurred for the clone ex-
pressing APE1NΔ33 (lane 5; almost 50% with respect to lane 2). Nu-
clear extracts obtained from HeLa cells reconstituted with ectopic 
APE1WT (lane 4) showed the same amount of bound complex as the 
control cell clone expressing a scrambled shRNA vector (indicated 
as SCR-1; recovery of almost 80% with respect to lane 2). 
Preincubation of the nuclear extract from the SCR-1 clone with an 
anti-APE1 antibody resulted in the formation of a supershifted com-
plex (Figure 2E, lane 3). This complex was absent when a nonrelated 
antibody was used (lane 6), clearly demonstrating that APE1, pres-
ent in the nuclear cell extract, is involved in the recognition of the 
Ligand Ka (ms × 105) Kd (1/s) KD (μM)
SIRT1-B nCaRE 0.270 0.105 3.90 ± 0.08
SIRT1-B mutated 0.0198 0.236 119 ± 8
polyT 0.004 0.112 308 ± 3
TABLE 1: Dissociation constant and kinetic parameter values as 
determined for APE1 by SPR analysis.
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(nCaRE-mut) caused only a slight reduction of the nCaRE-binding 
complex, in agreement with ChIP and SPR data, supporting the no-
tion of sequence-dependent binding specificity (unpublished data). 
These data were also confirmed with the endogenous APE1 pro-
moter via ChIP followed by high-throughput sequencing (ChIP-Seq) 
analyses (unpublished data), further demonstrating the physiologi-
cal relevance of these findings. Together these results confirm our in 
vitro observations (Figure 2) and support the hypothesis that, under 
basal conditions, APE1 is associated with the nCaRE-B sequence 
within the SIRT1 promoter also in vivo, possibly as part of a multipro-
tein complex.
We then evaluated whether APE1 binding to SIRT1 promoter 
plays a role in SIRT1 transcriptional regulation by performing pro-
moter-reporter assays. HeLa cells were cotransfected with a lu-
ciferase reporter vector bearing the SIRT1 promoter and APE1WT 
FLAG-tagged vector (Figure 4C). SIRT1 promoter-reporter assays 
showed that there was a significant increase in the luciferase signal 
detected in the presence of APE1 compared with that of the pro-
moter alone. We evaluated the effect of APE1 silencing on endog-
enous SIRT1 mRNA expression levels through an inducible shRNA 
knockdown strategy (Vascotto et al., 2009a,b). Endogenous APE1 
knockdown (CL.3) caused a significant reduction in the SIRT1 en-
dogenous expression levels (Figure 4D), which was rescued in cells 
reconstituted with a siRNA-resistant APE1 cDNA expression plasmid 
(WT). These data demonstrated a positive effect of APE1 on SIRT1 
transcriptional activation. Although unexpected, since previous data 
reported a transcriptional repressive role for APE1 through nCaRE 
sequence binding (Okazaki et al., 1991; Fuchs et al., 2003), these 
data agree with our previous observations from gene expression 
profiling analysis (Vascotto et al., 2009a), in which reduced expres-
sion of SIRT1 in APE1-knockdown HeLa cells was apparent.
Oxidative stress induces SIRT1 transcription via recruitment 
of BER enzymes
To better understand, at the molecular level, the transcriptional func-
tion exerted by APE1 through binding to nCaRE-B sequences, we 
investigated whether APE1’s positive role in SIRT1 transcription re-
lied on its enzymatic activity on DNA. First, we observed that under 
basal conditions APE1 has no endonuclease activity on the SIRT1 
nCaRE-B sequence, as assessed through an oligonucleotide cleav-
age assay (Figure 5A). APE1 cleavage, occurring at any site on the 
cruciform nCaRE-B sequence, should lead to a site-specific, single-
stranded break that can be detected by the appearance of an extra 
fragment in the cleavage assay. Even using an increasing amount of 
purified recombinant APE1 protein, we did not detect any nuclease 
activity that, on the contrary, was readily visible when using a 
radiolabeled 26-mer ds oligonucleotide containing a tetrahydro-
furan mimicking an AP site (here referred to as THF; Berquist et al., 
2008). Substitution of the guanine residue at position 12, within the 
predicted loop of the nCaRE-B sequence, with a THF residue re-
sulted instead in efficient APE1 cleavage activity on the nCaRE-B 
sequence. This activity depends on APE1 catalytic function, since 
the catalytically inactive APE1E96A mutant (Izumi et al., 1999) was un-
able to efficiently cleave the same substrate (Figure 5B).
Prompted by these findings, we hypothesized that the APE1-
positive function that we observed on the SIRT1 promoter may be 
ascribed to the APE1 catalytic activity on nCaRE-B sequences. This 
can occur after specific stimuli, such as oxidative stress, which can 
lead to abasic site formation on nCaRE-B sequences (Amente et al., 
2010; Francia et al., 2012). It is well known that SIRT1 expression 
and function are regulated by external stressors, including exposure 
to genotoxic agents (Cohen et al., 2004; Kim and Um, 2008; 
the absence or the presence of its target nCaRE oligonucleotide 
(Figure 3C, left). In particular, parallel experiments with a specific 
proteolytic enzyme (used at a defined APE1/protease weight/weight 
ratio) were carried out on a time-course basis on 1) isolated APE1, 2) 
APE1 complexed with SIRT1 nCaRE-B oligonucleotide, and 3) APE1 
complexed with PTH nCaRE-B oligonucleotide (Okazaki et al., 1992; 
Supplemental Figure S5 and Supplemental Table S4). This last was 
used as control. Resulting differential peptide maps provided infor-
mation on amino acid(s) eventually protected from proteolytic attack 
as result of their presence at the protein–DNA complex interface 
(Figure 3C, left). The data were interpreted according to the concept 
of “molecular shielding” of amino acids from proteolytic attack 
(Scaloni et al., 1998, 1999; Renzone et al., 2007) and were rational-
ized on the basis of x-ray crystallographic APE1 structures (Gorman 
et al., 1997; Beernink et al., 2001). To maximize information resulting 
from limited proteolysis experiments, we used different proteolytic 
enzymes in separate assays.
Figure 3C (right) summarizes the results of the limited proteolysis 
experiments, as obtained by using different proteases on recombi-
nant APE1 alone (Figure 3C, top) or after its complex formation with 
the SIRT1 nCaRE substrate (Figure 3C, bottom; see Supplemental 
Figure S5 and Supplemental Table S4 for experimental details). 
General considerations concerning the native protein are as follows. 
Preferential hydrolyzed peptide bonds on isolated APE1 gathered 
into a specific region of the protein, namely the most exposed seg-
ment, the unstructured N-terminal domain, which contained six pro-
teolytic sites (K6, K7, A9, A11, D15, and L17). An additional site was 
within the globular APE1 domain (L111). Of interest, no other cleav-
age sites were detected in other protein regions, although exposed 
on the molecular surface (Gorman et al., 1997; Beernink et al., 2001). 
After complex formation with nCaRE-B oligonucleotides, a marked 
protective effect was observed, as demonstrated by the large de-
crease in the number of proteolytic sites present in the N-terminal 
region (from six to one), thus confirming the involvement of this 
APE1 portion in binding to these DNA elements.
Transcriptional regulation of SIRT1 expression 
by APE1 protein
To determine whether the observations obtained in vitro regarding 
APE1 binding to SIRT1 nCaRE-B sequences have any relevance in 
vivo, we examined the APE1 occupancy of the nCaRE-B sequence 
in the SIRT1 promoter through chromatin immunoprecipitation 
(ChIP) analyses. To this purpose, we used HeLa cells cotransfected 
with a human SIRT1 promoter–containing plasmid (Yamamori et al., 
2010) and FLAG-tagged APE1WT- or APE1NΔ33-expressing plasmids. 
The amount of immunoprecipitated SIRT1 promoter was signifi-
cantly enriched in APE1WT-transfected cells compared with that ob-
tained from control cells transfected with the empty vector alone 
(Figure 4A). As expected, APE1NΔ33-transfected cells had a remark-
able reduction, although not completely so, in the amount of im-
munoprecipitated SIRT1 promoter. A similar degree of reduction 
was observed when ChIP analysis was performed by using a SIRT1 
promoter bearing a mutated sequence within the nCaRE-B motif 
(Figure 4B), whose reduced specificity was previously assessed 
through SPR analysis (Table 1 and Supplemental Figure S2). These 
experiments revealed that the mutation introduced in the nCaRE-B 
sequence significantly reduced the APE1 binding to DNA, lowering 
the affinity of the complex by 30-fold (KD = 119 ± 3 μM). Competi-
tive EMSA analyses were in agreement with these findings. In fact, 
addition of the unlabeled nCaRE ds oligonucleotide resulted in al-
most complete elimination of bound complex formation. On the 
other hand, competition with the unlabeled mutant nCaRE oligo 
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FIGURE 3: APE1 recognizes structured nCaRE sequences through its N-terminal domain. (A) Left, predicted cruciform 
structure of nCaRE SIRT1-B ds oligonucleotide. Arrows indicate the cleavage site of T7 endonuclease I and the length of 
the products. Right, 5′-32P-end-labeled nCaRE was preincubated (lane 4) or not (lane 3) with APE1 recombinant protein 
and then subject to T7 endonuclease digestion. (B) EMSA analysis of APE1 binding to nCaRE sequence after digestion 
with T7 endonuclease (lanes 7 and 8) or upon preincubation with APE1 and subsequent digestion with T7 endonuclease 
(lanes 9 and 10). Lane 1 is the probe alone; APE1 incubation with the probe was performed temporally before (1st) or 
after (2nd) T7 digestion; F shows the position of the free oligonucleotide probe. F** indicates the T7 endonuclease–
digested probe. Specific APE1/nCaRE interaction is indicated by the arrow. (C) Schematic representation of the amino 
acids within the N-terminal domain of APE1 and involved in nCaRE oligonucleotide binding. Left, proteolytic maps 
obtained after incubation of recombinant APE1 alone (top) or recombinant APE1 complexed with SIRT1 nCaRE-B 
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FIGURE 4: APE1 positively regulates SIRT1 expression at the promoter level. (A). Top, schematic representation of the 
human SIRT1 promoter used for HeLa transfection. For and Rev arrows indicated the reverse transcription-PCR primer 
designed for the quantification of the human SIRT1 nCaRE sequence bound to APE1. Bottom, ChIP assay for APE1-
nCaRE sequence association. Percentage of immunoprecipitated nCaRE DNA relative to that present in total input 
chromatin. Data were further normalized to the amount of immunoprecipitated protein. Western blot analysis was 
performed on total cell extracts (input) and immunoprecipitated material (IP) with specific antibody for FLAG and APE1. 
IB, immunoblot. (B) ChIP analysis on mutated human SIRT1 promoter. Top, base composition of the nCaRE SIRT1-B 
mutated sequence used for site-directed mutagenesis of SIRT1 promoter. Divergent sequences in the mutant nCaRE are 
bold. Bottom, HeLa cells were cotransfected with vector expressing APE1WT and, alternatively, wild-type or mutated 
hSIRT1 promoter. The histogram represents the amount of hSIRT1 promoter sequence that was immunoprecipitated. 
Data are percentage of input and are normalized to the amount of APE1 immunoprecipitated, as evaluated by Western 
blot analysis. (C) hSIRT1 promoter is activated in presence of APE1, as shown in the reporter assay. Western blot 
analysis showing the normalization of protein levels. (D) Analysis of SIRT1 mRNA level with qPCR in clones expressing 
APE1WT or APE1 silenced (CL.3) cells. Western blot analysis on protein extract of clones showing the suppression of 
endogenous APE1 expression upon 10 d of treatment with doxycycline.
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mass spectrometry analysis are indicated at the top of the corresponding chromatographic peaks. Right, proteolytic 
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FIGURE 5: Recruitment of BER enzymes on the SIRT1 promoter. (A) APE1 endonuclease activity on ds, nCaRE SIRT1-B 
radiolabeled oligonucleotide. A radiolabeled ds, THF-containing deoxyoligonucleotide (THF) was used as control. 
Reactions were performed with increasing amounts (picomoles) of recombinant APE1WT protein. (B) APE1 AP 
endonuclease activity on nCaRE SIRT1-B THF-containing probe incubated with increasing amounts of recombinant 
APE1WT protein or a catalytic inactive APE1 mutant (APE1E96A). (C) Reporter assay with HeLa cells transfected with 
hSIRT1 firefly reporter vector and challenged with increasing doses of H2O2 for 1 h as indicated. (D) qPCR analysis of 
SIRT1 mRNA levels in clones expressing APE1WT or APE1-silenced cells APE1CL.3 after 1 mM H2O2 treatment for 1 h. 
Western blot analysis on the protein extracts. (E) qPCR analysis of SIRT1, EGR-1, and EIF4EBP mRNA levels in APE1CL.3 
or APE1WT clones after 1 mM H2O2 treatment for 1 h. Data shown are reported as fold of activation after H2O2 
treatment. (F) Results of four independent ChIP analyses relative to accumulation of 8-oxodeoxyguanine, OGG1, APE1, 
and RNA polymerase II protein on the SIRT1 promoter after 1 mM H2O2 treatment for different times (as reported). 
Data are percentage of input and normalized to quantity of DNA immunoprecipitated by α-tubulin (α-tub). See 
Supplemental Figure S4 for detailed information.
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relatively low abundance on the SIRT1 nCaRE-B sequence; con-
versely, the polymerase was progressively recruited as soon as the 
oxidative stress began (15 min after H2O2 treatment). Afterward 
(40 min after H2O2 addition), RNAPII was again recruited on the 
SIRT1 promoter, showing a wave-like behavior. In concert with this 
observation, we also noticed augmented interaction between 
APE1 and RNPII in accordance with the kinetics observed during 
ChIP analysis (Supplemental Figure S8). This oxidatively induced 
recruitment of RNPII to the SIRT1 promoter may suggest that oxi-
dative stress can trigger SIRT1 transcriptional activation. One 
could envision a mechanism in which H2O2, causing oxidation of 
the guanine at the SIRT1 nCaRE-B sequence, promotes recruit-
ment of components of the base excision repair system—OGG1 
and APE1, together with proteins involved in nCaRE-B binding 
such as Ku70. When recruited to the SIRT1 promoter, APE1 
(through its endonuclease activity) produces nicks on the SIRT1 
nCaRE-B sequence, possibly favoring the DNA relaxation neces-
sary for the formation of chromatin loops that bring RNAPII at the 
transcription start site (Figure 6); this last enzyme in turn can initi-
ate transcription.
DISCUSSION
After its cloning by independent groups, first as a DNA-repair en-
zyme (Demple et al., 1991; Robson and Hickson, 1991) and then 
as a redox coactivator protein (Xanthoudakis and Curran, 1992), a 
number of articles described different APE1 functions, elucidating 
its involvement in several biological contexts. As the main apurinic/
apyrimidinic endonuclease in mammalian cells, APE1 is classically 
known for its essential function as a DNA-repair enzyme in the 
BER pathway. Besides this crucial role in the maintenance of ge-
nome stability, APE1 was demonstrated to be involved in redox 
signaling and the regulation of gene expression (Tell et al., 2010a; 
Wilson and Simeonov, 2010), supporting the notion that it is a 
multifunctional protein, with features that go beyond the classic 
activities of a DNA-repair enzyme. Of note, its multifunctional na-
ture suggests APE1 as an ideal candidate protein linking DNA-
damage sensing/repair and transcriptional regulation of genes 
during cell response to genotoxic damage. Among these non-
canonical activities, another interesting APE1 function is its ability 
to bind the nCaRE sequence of some gene promoters, thus acting 
as a transcriptional regulator. Okazaki’s group was the first to iden-
tify two nCaRE sequences within the PTH gene promoter (nCaRE-
A and nCaRE-B; Okazaki et al., 1991). The presence of these ele-
ments was also described in the regulatory region of a few other 
genes, such as human APE1 (Izumi et al., 1996), rat atrial natriuretic 
polypeptide (Okazaki et al., 1992), human renin (Fuchs et al., 
2003), and Bax (Bhattacharyya et al., 2009). Besides these few 
genes, no further evidence has been provided. However, since 
nCaRE-B elements are present within ALU repeats, which are 
widely distributed throughout the expressed genome, it is ex-
pected that APE1 could regulate the expression of a large number 
of genes. Here we performed an unbiased investigation of the 
whole human genome, searching for putative genes whose tran-
scription may be mediated through APE1’s ability to bind nCaRE-
B elements. In particular, although nCaRE elements seem to be 
active also at downstream regions (Izumi et al., 1996), here we 
specifically focused on nCaRE-B elements present only on the up-
stream sequence of human genes. In the near future, we plan to 
extend this approach to downstream and intron regions. Bioinfor-
matic analyses revealed a number of genes potentially regulated 
by APE1, which are involved in several pathways related to gene 
expression (Figure 1). Among the 57 candidate genes retrieved 
Yamamori et al., 2010). We therefore measured SIRT1 transcription 
after oxidative stress, such as that generated by H2O2 exposure. 
First, we demonstrated that SIRT1 promoter activation was in-
creased by H2O2 treatment in a concentration-dependent manner 
(Figure 5C). Next we examined the effect of APE1 silencing or re-
expression on SIRT1 transcriptional activation in HeLa cell clones 
upon H2O2 treatment (Figure 5D and Supplemental Figure S6). We 
treated control (SCR-1), APE1-silenced (CL.3), and APE1WT cell 
clones with 1 mM H2O2 for 1 h. SIRT1 mRNA levels were then evalu-
ated by quantitative PCR (qPCR) and compared with those for un-
treated clones. On oxidative treatment, SIRT1 mRNA significantly 
increased, and, of note, this response was higher in the presence of 
APE1WT protein, whereas it was lower in the case of APE1-knock-
down–expressing cells. The residual activation of SIRT1 mRNA ex-
pression, which was apparent also in APE1-knockdown cells, might 
be ascribable to the presence of residual endogenous APE1 protein 
and/or of further limiting factors, as already speculated (Chung 
et al., 1996; Kuninger et al., 2002; Bhattacharyya et al., 2009). The 
observed induction of SIRT1 mRNA transcription in HeLa cells upon 
oxidative stress correlates with a parallel increase in its protein lev-
els. Confirmation of the biological relevance of our findings comes 
from the observation of concomitant increased deacetylation activ-
ity of SIRT1 protein toward its substrate, that is, K382 of p53 (Vaziri 
et al., 2001; Supplemental Figure S6).
We also confirmed the general relevance of our model by testing 
other hypothetical APE1 target genes containing an nCaRE-B ele-
ment in their promoters and resulting dysregulation in the APE1-kd 
cell model (Figure 1 and Supplemental Table S2; Vascotto et al., 
2009a). To this aim, we evaluated by qPCR the expression levels, 
upon H2O2 treatment, of EGR-1 and eukaryotic translation initiation 
factor 4E–binding protein 1 (EIF4EBP1) in the HeLa cell inducible-kd 
(CL.3) clone and the reconstituted cell clone (WT) used here 
(Figure 5E). Similar results were obtained using another genotoxic 
agent, methyl methanesulfonate (Supplemental Figure S9). These 
data, showing inducible expression of these genes dependent on 
APE1 expression to a similar extent of that observed in the case of 
SIRT1, were suggestive of a general mechanism of gene activation 
upon DNA damage that involves APE1 binding to nCaRE-B 
elements.
To find a relationship between SIRT1 transcription induced by 
oxidative stress and the APE1 regulatory activity on the nCaRE-B 
sequences located within the promoter, we studied the dynamics 
of oxidative repair enzyme recruitment on the SIRT1 nCaRE-B se-
quence at early time upon H2O2 treatment. DNA base oxidation 
determines the formation of 8-oxodeoxyguanine (8-oxodG), which 
is recognized by the DNA glycosylase OGG1. This enzyme initi-
ates the BER pathway by removing the 8-oxodG lesion, which is 
further processed by APE1, which cleaves the apurinic site. To as-
sess the dynamics of occupation of the nCaRE-B sequence on the 
SIRT1 promoter by these enzymes upon oxidative stress, we per-
formed a time-course ChIP analysis on the SIRT1 nCaRE-B se-
quence after 1 mM H2O2 treatment (Figure 5F and Supplemental 
Figure S7). We immunoprecipitated SIRT1 nCaRE-B sequence 
with antibodies against 8-oxodG, OGG1, and APE1. We observed 
that the signal of 8-oxodG promptly reached its plateau 10 min 
after H2O2 treatment and subsequently decreased, concomitant 
with accumulation of OGG1, which is recruited immediately after 
(15 min), in accordance with the BER processes. Occupancy by 
APE1 follows OGG1 recruitment. To demonstrate a direct link be-
tween DNA repair and SIRT1 transcriptional initiation, we exam-
ined the assembly of RNA polymerase II (RNPII) on the SIRT1 
nCaRE-B sequence. Under basal condition, RNPII was found with 
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ing that this deacetylase controls the 
acetylation status of APE1 lysine residues 
K6-7 (Yamamori et al., 2010) and K27-35, 
thus modulating the subnuclear distribu-
tion of this protein and coordinating its 
enzymatic functions in the BER pathway 
(Lirussi et al., 2012). Therefore we hypoth-
esized the existence of a possible auto-
regulatory loop between the two proteins: 
APE1 modulates SIRT1 expression, which, 
in turn, regulates APE1 function through 
deacetylation.
To investigate APE1’s transcriptional reg-
ulatory function on SIRT1 expression, we 
first examined APE1’s ability to bind the 
nCaRE-B sequences found in the SIRT1 pro-
moter. Through different in vitro approaches, 
we showed that APE1 is able to bind SIRT1 
nCaRE-B sequences (Figures 2 and 3). In 
particular, by a combination of EMSA and 
SPR analyses with limited proteolysis experi-
ments, we demonstrated that the APE1 N-
terminal domain is essential for the proper 
binding of these elements. The essential 
role of this protein domain in DNA binding 
is remarkable, particularly if one considers 
the phylogenesis of the nCaRE-B elements 
and that of the APE1 N-terminal region. 
nCaRE-B sequences are present within ALU 
repeats, which belong to the short inter-
spersed nucleotide element family of repeti-
tive sequences that originally derived from 
the reverse transposition of 7SL RNA. This 
event took place in the genome of an ances-
tor of Supraprimates (Kriegs et al., 2007): 
these repetitive elements have been found 
exclusively in primates (Deininger et al., 
1981), scandentians (Nishihara et al., 2002), 
and rodents (Krayev et al., 1980), all mem-
bers of the placental mammalian clade 
Supraprimates (Euarchontoglires; Murphy 
et al., 2001). Similarly, information on the se-
quence homology of the APE1 N-terminal 
domain across species points to the recent 
phylogenetic acquisition of this region. 
Sequence conservation of this domain is 
very high in mammals but almost absent in 
other organisms, with the exception of 
Danio rerio, Dictyostelium, and Drosophila. 
Accordingly, it could be envisioned that 
once ALU elements appeared in primates 
and were stabilized in their genomes, 
progressively losing their transcriptional po-
tential, these organisms needed to evolve 
novel mechanisms to cope with the acquired 
RNA Pol II regulatory sites present within the 
ALU region. The concomitant acquisition of 
the APE1 N-terminal domain in mammals 
could explain new modulatory functions to-
ward these DNA elements. The observation that specific K residues 
(K24-27) within this reduced APE1 portion seem to be required for 
the correct binding of nCaRE-B (unpublished data) nicely fits with 
from our bioinformatic analysis, we chose to study the human 
deacetylase SIRT1, which bears two nCaRE-B elements in its pro-
moter. Increased interest in SIRT1 was due to recent articles show-
FIGURE 6: Mechanistic model for the role of APE1 in oxidatively mediated SIRT1 transcription. 
Under normal conditions, APE1, together with other protein factors, is bound to the nCaRE 
element present within the SIRT1 promoter involved in the basal activation of SIRT1 
transcription. Conversely, upon oxidative stress conditions, DNA oxidation determines the 
formation of 8-oxodeoxyguanine (8-oxoG) lesions at the nCaRE sequence present in the SIRT1 
promoter, which are recognized and processed by BER enzymes, including APE1. The nicks 
introduced at the chromatin level by APE1 during 8-oxoG removal might promote the formation 
of chromatin loops moving the active form of RNA polymerase II closer to the TSS of the gene, 
turning on the transcription.
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sequence of SIRT1 promoter in vivo and confirmed this through 
ChIP-Seq analysis (unpublished data). In particular we observed 
that APE1 positively affects SIRT1 gene transcription. Although 
APE1 was implicated in the repression of PTH gene transcription in 
a Ca2+-dependent manner, APE1 overexpression activated the 
SIRT1 promoter (Figure 4C) apparently through a Ca2+-indepen-
dent mechanism. This unexpected positive function on the tran-
scription of an nCaRE-containing promoter was also reported in 
other work, in which the authors suggested that the role of the 
nCaRE sequences in the context of different promoters and cells 
conditions could affect nCaRE activity (Bhakat et al., 2003; Fuchs 
et al., 2003). Of interest, we noticed that the positive effect of APE1 
was particularly pronounced during oxidative stress, through its 
binding to SIRT1 nCaRE-B sequences (Figure 5D). Treatment with 
H2O2 leads to activation of the SIRT1 promoter, which determines 
an increase of the corresponding transcriptional expression in an 
APE1-dependent manner. This positive transcriptional effect was 
also observed when we looked at the expression of other genes 
that have nCaRE-B elements in their promoters (Figure 5E), thus 
corroborating the hypothesis of a general mechanism of SIRT1 
gene activation upon DNA damage that involves functional activa-
tion of APE1. These findings are in line with data from Yamamori 
et al. (2010) showing that genotoxic insult stimulates SIRT1 expres-
sion and therefore its deacetylase activity on APE1 K6/7, favoring 
APE1 binding to XRCC1. Of interest, these authors sowed that a 
decrease of APE1 acetylation at later times after oxidative treat-
ment is usually accompanied by SIRT1 up-regulation. Together 
these findings are in accordance with a model of a positive auto-
regulatory loop between the two proteins. Thus SIRT1 seems to be 
involved in a feedback mechanism that shuts off the cellular re-
sponse mediated by APE1 acetylation (Yamamori et al., 2010). Fur-
ther proof of APE1 and SIRT1 collaboration comes from the recent 
demonstration that APE1 stimulates SIRT1 activity in endothelial 
cells by reducing thiol moieties of cysteine residues in SIRT1, thus 
protecting endothelium from oxidative stress (Jung et al., 2013).
It has been suggested that DNA oxidation could trigger posi-
tive transcription in the context of Myc-mediated transcription 
through the involvement of BER enzymes, including APE1 (Perillo 
et al., 2008; Gillespie et al., 2010). Similarly, we speculated that 
APE1’s positive effect on SIRT1 transcription might depend on 
APE1 endonuclease activity over the nCaRE-B elements present 
within the SIRT1 promoter. We propose a model in which oxida-
tive-mediated DNA repair and gene transcription are linked 
(Figure 6). During oxidative stress, DNA oxidation determines the 
formation of 8-oxodG lesions, which are recognized and pro-
cessed by enzymes of the BER pathway, including APE1. In our 
model, the oxidative burst is an early event, essential for formation 
of a productive transcription initiation complex, which relies on 
initial recruitment of BER enzymes. The nicks introduced at the 
chromatin level by APE1 during 8-oxodG removal might promote 
the local relaxation required for formation of chromatin loops 
moving the active form of RNA polymerase II closer to the TSS of 
the gene, as previously recruited by APE1 on the nCaRE-B se-
quence, turning on the transcription. Our data therefore can be 
generalized to a regulatory model for all genes that contain 
nCaRE-B elements. Accordingly, a new hypothesis can be pro-
posed for the molecular activation of specific genes during early 
response to DNA damage. This model links DNA-repair enzymes 
and transcriptional regulation effectors and may constitute a gen-
eral model for explaining the adaptive cell response to oxidative 
stress involving gene regulation and DNA damage in which APE1 
plays a central role.
this hypothesis. The zebrafish homologue of APE1, which shares 
<40% of the N-terminal amino acid sequence with the human pro-
tein and lacks two of five K residues in this region, is indeed no 
longer able to stably bind these nCaRE-B sequences (Figure 2B; 
Poletto et al., 2013). Similar results were obtained using a human 
recombinant APE1 mutant protein bearing specific K-to-A multiple 
substitution at K27/31/32/35, in which the positive charges at the 
amino acid side chain were removed to mimic a condition similar to 
that exerted by K acetylation (unpublished data).
The APE1 N-terminal domain seems required for stable binding 
to the SIRT1 nCaRE-B elements, even though it is not sufficient 
(Poletto et al., 2013). EMSA analysis, performed with nuclear extracts 
of HeLa cells expressing the deletion form of APE1, demonstrated 
that APE1 is part of a multiprotein complex, not the limiting factor in 
the binding reaction. As speculated by Okazaki and also in later 
work, the binding affinity observed for the multiprotein complex is 
higher than that detected when using purified APE1 protein alone 
(Figure 2). This suggested that other factors are necessary and coop-
erate with APE1 to fully exert this function, confirming previous ob-
servations (Chung et al., 1996; Kuninger et al., 2002). The two sub-
units of Ku antigen (Ku70 and Ku80) were among the protein factors 
already described by Chung et al. (1996) to be involved in the spe-
cific binding of nCaRE-A sequences. Here we demonstrated that 
Ku70 binding is not exclusively limited to the nCaRE-A elements, 
since we identified this protein in the complex that binds to the 
nCaRE-B sequence of SIRT1. The Ku heterodimer is a main compo-
nent of the nonhomologous end-joining pathway that repairs DNA 
double-strand breaks (DSBs), which are generally produced upon 
extensive oxidative and infrared damage to DNA (Lieber, 2010). The 
peculiar structure of Ku allows recognition and tight binding to DSBs, 
together with the recruitment of DNA-PKcs and other factors to form 
the active protein kinase complex DNA-PK that facilitates processing 
and ligation of broken ends (Walker et al., 2001; Postow, 2011). Its 
involvement in nCaRE binding is not clear, but emerging evidence 
suggests a biological role in its noncanonical functions (Adelmant 
et al., 2012). We envisage that Ku70 association with nCaRE ele-
ments could further facilitate APE1 binding, especially after DNA 
damage, since we observed increased interaction between the two 
proteins upon oxidative stress (Supplemental Figure S8).
We also better characterized the topology of the APE1-nCaRE 
complex. The palindromic nature of nCaRE-B sequences was 
described by Okazaki et al. (1991), who suggested the possible in-
volvement of a dimeric nuclear protein in this process. Here we sug-
gest that the SIRT1 nCaRE-B, due to its palindromic sequence, can 
potentially fold into a cruciform-like structure, and APE1 binding 
activity toward these elements strongly relies on the secondary con-
formation adopted by the oligonucleotide, as established for other 
DNA and RNA substrates (Figure 3B and Supplemental Figure S4; 
Poletto et al., 2013). Formation of similar cruciform-like structures by 
palindromic sequences has been described in eukaryotic cells, and 
their biological consequences have been related to different pro-
cesses, including regulation of transcriptional events when present 
in close proximity to gene promoters (Pearson et al., 1994; 
Shlyakhtenko et al., 2000; Alvarez et al., 2002; Cunningham et al., 
2003; Kurahashi et al., 2004). We therefore hypothesize a similar 
mechanism for SIRT1 transcriptional regulation. However, the re-
quirement of a specific recognition motif cannot be excluded since 
mutations in the SIRT1 nCaRE-B sequence, determining only a par-
tial disruption of the oligonucleotide secondary structure, did not 
completely affect APE1-binding activity in vivo (Figure 4B).
We further studied APE1’s transcriptional function on the SIRT1 
promoter. We found that APE1 is able to bind the nCaRE-B 
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et al., 2007; Nogales-Cadenas et al., 2009; Tabas-Madrid et al., 
2012), selecting Homo sapiens as the source for annotations and 
Biological Process as the GO category to perform the gene annota-
tion cooccurrence analysis.
Cell culture and transient transfection experiments
HeLa cells were grown in DMEM (Invitrogen, Carlsbad, CA) supple-
mented with 10% fetal bovine serum (Euroclone, Milan, Italy), 100 U/
ml penicillin, and 10 μg/ml streptomycin sulfate. One day before 
transfection, cells were seeded in 10-cm plates at a density of 3 × 106 
cells/plate. Cells were then transiently transfected with plasmids of 
interest by using Lipofectamine 2000 reagent (Invitrogen), according 
to the manufacturer’s instructions. Cells were harvested 48 h after 
transfection.
Inducible APE1 knockdown and generation of APE1 
knock-in cell lines
Inducible silencing of endogenous APE1 and reconstitution with 
mutant proteins in HeLa cell clones was performed as described 
(Vascotto et al., 2009a,b). For inducible shRNA experiments, doxy-
cycline (1 μg/ml) (Sigma-Aldrich, St. Louis, MO) was added to the 
cell culture medium, and cells were grown for 10 d.
Plasmids and expression of recombinant proteins
Plasmid containing the human SIRT1 promoter was kindly provided by 
K. Irani, University of Pittsburgh (Pittsburgh, PA). This plasmid consists 
of a fragment of the human SIRT1 promoter (–1266 to +137 relative to 
transcription start site) cloned into the pGL4.1 firefly luciferase reporter 
vector (Promega, Madison, WI; Yamamori et al., 2010). The human 
SIRT1 promoter carrying the mutation at nCaRE-B sequences was 
generated with a Site-Directed Mutagenesis Kit (Stratagene, Santa 
Clara, CA), using the primers SIRT1-B mut, forward, 5′-TCATCTAGG-
TTTTATTTATATATTTTTTTGCTAAGG AGCGTCGCTCTTGCTGC C-
CAGGCTGGTGTG-3′, and SIRT1-B mut, reverse, 5′-CACACCAGCC-
TGGGC AGCAAGAGCGACGCTCCTTAGCAAAAAAATATATAAATA
AAACCTAGATGA-3′.
Expression and purification of recombinant proteins from E. coli 
were performed as previously described (Vascotto et al., 2009b; 
Fantini et al., 2010).
Antibodies and Western blot analysis
For Western blot analyses, the indicated amounts of cell extracts 
were resolved in 10% SDS–PAGE and transferred to nitrocellulose 
membranes (Schleicher & Schuell, BioScience, Dassel, Germany). 
Membranes were blocked with 5% (wt/vol) nonfat dry milk in phos-
phate-buffered saline containing 0.1% (vol/vol) Tween 20 and 
probed with monoclonal anti-FLAG antibody (Sigma), monoclonal 
anti-APE1 antibody (Vascotto et al., 2009a), monoclonal anti-Ku70 
(sc-12729; Santa Cruz Biotechnology, Santa Cruz, CA), monoclonal 
anti–RNA polymerase II (Abcam, Cambridge, MA), monoclonal anti-
SIRT1 (Abcam), monoclonal anti-p32 (Santa Cruz Biotechnology), 
and polyclonal anti-p53(acetyl K382) (Abcam). Blots were devel-
oped by using the enhanced chemiluminescence procedure 
(GE Healthcare, Piscataway, NJ) or Western Lightning Ultra (Perkin 
Elmer, Waltham, MA). Data normalization was performed by using a 
monoclonal anti-tubulin antibody (Sigma). Blots were quantified by 
using a Chemidoc XRS video densitometer (Bio-Rad, Hercules, 
CA).
Alignments and secondary structure predictions
Multiple alignments were performed using CLUSTALW2 (www.ebi 
.ac.uk/Tools/msa/clustalw2/).
MATERIALS AND METHODS
Bioinformatic analysis
All human and mouse DNA sequences were retrieved from the En-
sembl database, release 56 (www.ensembl.org/), by using a dedi-
cated program written in Perl that collects entries from this archive. 
A sequence window was selected that contains 5′ genomic DNA of 
every gene coding for a protein. This region extends from 6000 
base pairs upstream and 1000 base pairs downstream of each tran-
scriptional start site. Gene Ontology (GO) annotations were ob-
tained from the Ensembl database by using the data-mining tool 
BioMart (www.ensembl.org/; Spudich et al., 2007). Human and 
mouse promoter regions were scanned for significant similarities to 
nCaRE-B by using Glsearch as program for local alignment (avail-
able in the Fasta3 program package; Pearson, 2000). Glsearch was 
chosen because it calculates an alignment that is global in the query 
and local in the library. The following nCaRE-B sequences were used 
as query (Izumi et al., 1996):
Alignments were computed with Altschul and Gish’s statistical 
estimates, which are more suitable for searching short query se-
quences (–z 3 option; Altschul, 1991). We selected only those pro-
moter genes that showed one or more matches for nCaRE-B 
sequences, allowing up to two mismatches in the case of the hu-
man genome and up to three mismatches in the case of the mouse 
genome; in fact, in the latter case, most alignments were found 
with three mismatches. From mouse promoter genes that con-
tained nCaRE-B elements, we retrieved only orthologous human/
mouse genes, as obtained from the BioMart Ensembl database. 
For the microarray filter, we cross-checked human genes selected 
from alignment search with microarray data obtained from the 
gene expression profile of HeLa cells silenced for APE1 by RNA 
interference (Vascotto et al., 2009a). The GO filter identified co-
regulated human genes, as determined by microarray analysis, 
studying the prevalence of their GO annotation terms. This analy-
sis was obtained by using a Perl program kindly provided by Corà 
et al. (2004), which performs an exact Fisher’s test based on hyper-
geometric distribution to determine whether the term appears 
in the set significantly more often than what is expected by 
chance. This program uses four different entries: 1) a file contain-
ing the whole GO database structure (OBO version 1.2; www 
.geneontology.org/); 2) the list of genes from the whole human 
genome, 4) a list of all genes with all the GO terms associated with 
them (as obtained from Ensembl), and 4) the set of genes to be 
tested. In general, a GO annotation term was considered to be 
significantly overexpressed when the corresponding p value (not 
corrected for multiple testing) was <1E-4. Phylogenetic footprint-
ing analysis consisted of the last selection from significant data 
obtained from the GO filter of that gene also present in the mouse 
orthologous data set.
Gene annotation co-occurrence analysis
Gene identifiers corresponding to the list of 57 putative genes regu-
lated by APE1 were submitted to GeneCodis (http://genecodis.cnb 
.csic.es/), a Web-based tool for ontological analysis (Carmona-Saez 
Name Sequence (5′ to 3′)
nCaRE-B (PTH) TTTTTGAGACAGGGTCTCACTCTG
nCaRE-B1 (APE1) TTTTGAGACAGTCTCAGCTCTG
nCaRE-B2 (APE1) TTTTGAGACAGAGTTTCACTCTTG
Volume 25 February 15, 2014 APE1 regulates SIRT1 gene expression | 545 
14, which is cleaved to a 14-mer in the presence of AP endonu-
clease activity. Alternatively, a 5′-32P-end-labeled ds SIRT1-B 
nCaRE-B oligonucleotide or a 5′-32P-end-labeled ds nCaRE SIRT1-
B oligonucleotide, bearing a single THF residue at position 12 
(bold) 5′-TTTTTGAGACGGAGTTTCGCTCTTG-3′ (Integrated DNA 
Technologies, Munich, Germany), was used. The conversion of the 
radiolabeled THF-containing oligonucleotide substrate (S) to the 
shorter product (P) was evaluated on a denaturing 20% polyacryl-
amide gel.
Reporter assays
For reporter assay experiments, we used a human SIRT1 promoter 
plasmid allowing for promoter activity measurements upon lu-
ciferase assay, as already described (Yamamori et al., 2010). To this 
purpose, 2.5 × 104 HeLa cells were seeded in a 96-well plate and 
cotransfected with 15 ng of human SIRT1 promoter, 0.3 ng of a 
constitutive Renilla reporter plasmid, and 75 ng of a vector express-
ing FLAG-tagged APE1 protein. When performing luciferase assays 
upon H2O2, cells were challenged with increasing amounts of H2O2 
in serum-free medium for 1 h at 37°C, and then firefly and Renilla 
luciferase activities were measured 24 h after the treatment by using 
the Dual-Glo Luciferase assay system (Promega), according to man-
ufacturer’s recommendations. Firefly activity was normalized to Re-
nilla activity to correct for differences in transfection efficiency. Re-
sults are from triplicate experiments.
Quantitative PCR
Total RNA from cell lines was extracted with the SV Total RNA isola-
tion System kit (Promega). One microgram of total RNA was reverse 
transcribed using the iScript cDNA synthesis kit (Bio-Rad), accord-
ing to the manufacturer’s instructions. Quantitative reverse-tran-
scription PCR was performed with a CFX96 Real-Time System 
(Bio-Rad) using iQ SYBR Green Supermix (Bio-Rad). Primer se-
quences for human SIRT1 were those reported in Yamamori et al. 
(2010). Human glyceraldehyde-3-phosphate dehydrogenase was 
used as internal control; sense, 5′-CCCTTCATTGACCTCAACTA-
CATG-3′; antisense, 5′-TGG GATTTCCATTGATGACAAGC-3′.
Surface plasmon resonance analysis
Real-time binding assays were performed on a Biacore 3000 SPR 
instrument (GE Healthcare). Biotinylated ds oligonucleotides were 
immobilized on an SA-chip at the desired level, as a result of their 
injection at a concentration of 500 nM in HBS (20 mM 
4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid, 150 mM NaCl, 
3.4 mM EDTA, and 0.005% [vol/vol] P20 surfactant, 0.1 mM Tris(2-
carboxyethyl)phosphine) at 10 μl/min as flow rate. Flow cell 2 con-
tained 100 RU of poly(dT); flow cells 3 and 4 contained 77 and 
60 RU of SIRT1-B nCaRE-B and SIRT1-B nCaRE-B mutated, re-
spectively; and flow cell 1 (with streptavidin) was left blank to be 
used as a reference surface. APE1 and its deletion mutant APE1NΔ33 
were serially diluted in running buffer to the indicated concentra-
tions and injected at a flow rate of 20 μl/min for 4.5 min at 20°C. 
Disruption of any complex that remained bound after a 3-min dis-
sociation was achieved by using an injection of 1 M NaCl at 20 μl/
min for 1 min. The BIAevaluation analysis package, version 4.1 
(GE Healthcare), was used to subtract blank signal and evaluate 
kinetic and dissociation constants. Kinetic parameters were esti-
mated assuming a 1:1 binding model and using Evaluation, ver-
sion 7 4.1 (GE Healthcare). An affinity steady-state model was ap-
plied to fit the RUmax data versus protein concentrations, and 
fitting was performed with Prism, version 4.00 (GraphPad, San 
Diego, CA; Fantini et al., 2010).
Potential secondary structures for SIRT1-B nCaRE-B oligonucle-
otide were determined by using the mfold Web Server program 
(http://mfold.rna.albany.edu/?q=mfold). Structure predictions were 
run by setting the program parameters as close as possible to the 
conditions used in binding assays (37°C and 50 mM monovalent 
cation).
Chromatin immunoprecipitation analysis
ChIP assay was performed by using a protocol described previously 
(Lirussi et al., 2012) on HeLa cells cotransfected with hSIRT1 pro-
moter and APE1-FLAG–tagged expressing vectors.
Preparation of nuclear cell extracts
Nuclear protein extracts were prepared as described earlier (Ziel 
et al., 2005).
Electrophoretic mobility shift assay analysis
APE1 binding to nucleic acids was assessed as already described 
(Fantini et al., 2010), with some modifications. Briefly, the indi-
cated amount of recombinant proteins or 5 μg of the reported 
nuclear extract was incubated at 37°C for 15 min with 250 pmol of 
unlabeled poly(dT) or 250 ng of sonicated salmon sperm DNA 
(Sigma). A 2.5-pmol amount of 32P-labeled, ds oligonucleotides 
was then added, incubated for additional 15 min, and further sep-
arated onto a native 6% wt/vol polyacrylamide gel at 150 V for 4 h. 
When performing supershift assays, 5 μl of monoclonal anti-APE1 
(Vascotto et al., 2009a), anti-Ku-70 (sc-12729; Santa Cruz Biotech-
nology) or anti-P2Y6 (Alomone Labs, Jerusalem, Israel) was prein-
cubated with HeLa nuclear extract from APE1SCR-1 clone at 4°C 
for 3 h.
Oligonucleotides used for EMSA were the following:
T7 endonuclease I footprinting
Footprinting analysis on the SIRT1 nCaRE-B sequence was con-
ducted using T7 endonuclease I. Briefly, 5′-32P-end-labeled nCaRE-
B SIRT1-B was digested with 5 U of T7 endonuclease I at 37°C for 
1 h and then incubated with 35 pmol of APE1 recombinant protein 
for 15 min at 37°C. The reaction mixtures were then loaded and 
separated for 2 h onto a denaturing 8 M urea sequencing gel. After 
separation, the gel was incubated for 30 min in a 10% methanol and 
10% acetic acid solution and then wrapped in Saran wrap and ex-
posed to film for autoradiography.
Determination of AP endonuclease activity
Determination of APE1 AP endonuclease activity was performed 
using an oligonucleotide cleavage assay, as described previously 
(Vascotto et al., 2009b). The indicated amount of recombinant 
APE1 protein was incubated with a 5′-32P-end-labeled 26-mer ds 
oligonucleotide containing a single THF artificial AP site at position 
Name Sequence (5′ to 3′)
nCaRE-B 
SIRT1-A
Forward TTTTTGAGACAGAGTTTCACTCTTG
Reverse CAAGAGTGAAACTCTGTCTCAAAAA
nCaRE-B 
SIRT1-B
Forward TTTTTGAGACGGAGTTTCGCTCTTG
Reverse CAAGAGCGAAACTCCGTCTCAAAAA
Poly(dT) Forward TTTTTTTTTTTTTTTTTTTTTTTT
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Limited proteolysis
Suitable experimental conditions were chosen by testing proteolysis 
with different enzyme/substrate values; no preventive removal of 
DNA was performed. Thus limited proteolysis experiments on 
recombinant APE1 were conducted in 50 mM NH4HCO3, pH 7.5 
(reaction buffer), at 37°C by using an enzyme-to-substrate ratio 
ranging from 1:500 to 1:5000 (wt/wt). Three identical aliquots of 
APE1 (500 pmol) were combined with reaction buffer or DNA 
nCaRE-B ds oligonucleotides (PTH or nCaRE SIRT1-B; 5:1 mol DNA/
protein) dissolved in reaction buffer to generate samples (100-μl 
final volume each), which were incubated for 15 min at 37°C before 
protease addition. After digestion started, the extent of proteolysis 
was monitored on a time-course basis by sampling 10 μl of the mix-
ture at time intervals ranging from 5 to 120 min. Reaction samples 
were immediately quenched with 5% formic acid and then frozen in 
dry ice before liquid chromatography–electrospray ionization–mass 
spectrometry (LC-ESI-MS) analysis.
LC-ESI-MS analysis
APE1 digests were analyzed with a Q-TOF Premier mass spectrom-
eter (Waters, Milford, MA) equipped with a nanospray source. Pep-
tide mixtures were separated on an Atlantis C18 column (100 μm × 
100 mm, 3 μm), using a linear gradient ranging from 30 to 60% ac-
etonitrile in 1% formic acid, over a period of 50 min at a flow rate of 
800 nl/min. Spectra were acquired in the m/z = 650–2500 range. 
Data were processed by using MassLynx software (Waters). Mass 
calibration was performed using multiply charged ions from horse 
heart myoglobin (Sigma). Depending on polypeptide size, mass val-
ues are reported as monoisotopic or average values. Observed 
mass values are assigned to specific polypeptides by using Paws 
software (Proteometrics, New York, NY), based on APE1 sequence 
and selectivity of the protease used for protein digestion.
Statistical analysis
Statistical analyses were performed by using the Excel (Microsoft, 
Redmond, WA) data analysis program for Student’s t test analysis. 
p < 0.05 was considered as statistically significant.
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